https://orcid.org/0000-0001-7594-7280
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L. Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutiérrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J. Blanco, Cruz Santos, José L. Rodríguez-Peralto, Laura Sanz & Luis Álvarez-Vallina. (2023) A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. OncoImmunology 12:1.
Read now
Read now
Christopher B. Lietz, Ekaterina Deyanova, Younhee Cho, Jon Cordia, Sarah Franc, Sally Kabro, Steven Wang, David Mikolon & Douglas D. Banks. (2023) Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity. mAbs 15:1.
Read now
Read now
Hélène Kaplon, Alicia Chenoweth, Silvia Crescioli & Janice M. Reichert. (2022) Antibodies to watch in 2022. mAbs 14:1.
Read now
Read now
Articles from other publishers (13)
Kilian Mayr, Thomas Weindl, Achim Gärtner, Julien Camperi, Thomas Maetzke, Markus Förster, Thomas Nachtigall, Frank Steiner, Annette Vogt, Fabian Hosp & Michael Mølhøj. (2023) Novel Multidimensional Liquid Chromatography Workflow with In-Loop Enzymatic Digests of Multiple Heart-Cuts for Fast and Flexible Characterization of Biotherapeutic Protein Variants. Analytical Chemistry 95:7, pages 3629-3637.
Crossref
Crossref
Xuan Cao, Jaron Castillo Sanchez, Tapan P. Patel, Zhiyong Yang, Chuanyu Guo, Danyal Malik, Anuoluwapo Sopeyin, Silvia Montaner & Akrit Sodhi. (2023) Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab. Journal of Clinical Investigation 133:2.
Crossref
Crossref
Wolfgang Koehnlein, Annika Holzgreve, Klaus Schwendner, Romas Skudas & Florian Schelter. (2023) Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin. Journal of Chromatography A 1687, pages 463696.
Crossref
Crossref
Shrestha Dutta, Swatilekha Ghosh, Abhishek Mishra & Rajgourab Ghosh. (2022) Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment. Journal of Proteins and Proteomics.
Crossref
Crossref
Marina Natoli, Klas Hatje, Pratiksha Gulati, Fabian Junker, Petra Herzig, Zhiwen Jiang, Iakov I Davydov, Markus Germann, Marta Trüb, Daniel Marbach, Adrian Zwick, Patrick Weber, Stefan Seeber, Mark Wiese, Didier Lardinois, Viola Heinzelmann-Schwarz, Robert Rosenberg, Lothar Tietze, Kirsten D Mertz, Pablo Umaña, Christian Klein, Laura Codarri-Deak, Henry Kao & Alfred Zippelius. (2022) Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. Journal for ImmunoTherapy of Cancer 10:11, pages e005548.
Crossref
Crossref
Adriana Kovacova. (2022) Faricimab for treatment of diabetic macular oedema. Practical Diabetes 39:6, pages 8-10.
Crossref
Crossref
Sławomir Liberski, Małgorzata Wichrowska & Jarosław Kocięcki. (2022) Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review. International Journal of Molecular Sciences 23:16, pages 9424.
Crossref
Crossref
Jiewen Chen, Chundong Huang, Wei Zhao, Jun Ren, Fangling Ji & Lingyun Jia. (2022) SnoopLigase Enables Highly Efficient Generation of C–C-Linked Bispecific Nanobodies Targeting TNF-α and IL-17A. Bioconjugate Chemistry 33:8, pages 1446-1455.
Crossref
Crossref
Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, Diana Darowski, Christian Jost, Kay-Gunnar Stubenrauch, Joerg Benz, Anne Freimoser-Grundschober, Ekkehard Moessner, Pablo Umana, Marion Subklewe, Stefan Endres, Christian Klein & Sebastian Kobold. (2022) Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors. Journal for ImmunoTherapy of Cancer 10:7, pages e005054.
Crossref
Crossref
Paul J. Carter & Arvind Rajpal. (2022) Designing antibodies as therapeutics. Cell 185:15, pages 2789-2805.
Crossref
Crossref
Ha Gyeong Shin, Ha Rim Yang, Aerin Yoon & Sukmook Lee. (2022) Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. International Journal of Molecular Sciences 23:10, pages 5686.
Crossref
Crossref
Ayuob Aghanejad, Samad Farashi Bonab, Maryam Sepehri, Fatemeh Sadat Haghighi, Ali Tarighatnia, Christopher Kreiter, Nader D. Nader & Mohammad Reza Tohidkia. (2022) A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. International Journal of Biological Macromolecules 207, pages 592-610.
Crossref
Crossref
Ingrid Grunert, Katrin Heinrich, Juliane Ernst, Michael Hingar, Alexandre Briguet, Michael Leiss, Manfred Wuhrer, Dietmar Reusch & Patrick Bulau. (2022) Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability. ACS Omega 7:4, pages 3671-3679.
Crossref
Crossref